Royal Bank of Canada »

Summit Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $86k 33k 2.57
2023-09-30 $35k 20k 1.81
2023-06-30 $29k 12k 2.42
2022-12-31 $8.8k 2.6k 3.41
2021-06-30 $11k 1.5k 7.15
2021-03-31 $0 21 0.00